Your browser doesn't support javascript.
loading
Association of CSF biomarkers with MRI brain changes in Alzheimer's disease.
Seidu, Nazib M; Kern, Silke; Sacuiu, Simona; Sterner, Therese Rydberg; Blennow, Kaj; Zetterberg, Henrik; Lindberg, Olof; Ferreira, Daniel; Westman, Eric; Zettergren, Anna; Skoog, Ingmar.
Afiliación
  • Seidu NM; Neuropsychiatric Epidemiology (EPINEP) Centre for Ageing and Health (AGECAP) Institute of Neuroscience and Physiology Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
  • Kern S; Neuropsychiatric Epidemiology (EPINEP) Centre for Ageing and Health (AGECAP) Institute of Neuroscience and Physiology Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
  • Sacuiu S; Department of Psychiatry Cognition and Old Age Psychiatry Sahlgrenska University Hospital, Region Västra Götaland Gothenburg Sweden.
  • Sterner TR; Neuropsychiatric Epidemiology (EPINEP) Centre for Ageing and Health (AGECAP) Institute of Neuroscience and Physiology Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
  • Blennow K; Department of Psychiatry Cognition and Old Age Psychiatry Sahlgrenska University Hospital, Region Västra Götaland Gothenburg Sweden.
  • Zetterberg H; Division of Clinical Geriatrics Department of Neurobiology Care Sciences and Society Center for Alzheimer Research Karolinska Institutet Stockholm Sweden.
  • Lindberg O; Cognitive Disorders Clinic Theme Inflammation and Aging Karolinska University Hospital Stockholm Sweden.
  • Ferreira D; Neuropsychiatric Epidemiology (EPINEP) Centre for Ageing and Health (AGECAP) Institute of Neuroscience and Physiology Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
  • Westman E; Aging Research Center Department of Neurobiology Care Sciences and Society Karolinska Institutet and Stockholm University Stockholm Sweden.
  • Zettergren A; Department of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology Sahlgrenska Academy University of Gothenburg Gothenburg Sweden.
  • Skoog I; Clinical Neurochemistry Laboratory Sahlgrenska University Hospital, Region Västra Götaland Gothenburg Sweden.
Alzheimers Dement (Amst) ; 16(1): e12556, 2024.
Article en En | MEDLINE | ID: mdl-38406609
ABSTRACT
The relation between cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) and magnetic resonance imaging (MRI) measures is poorly understood in cognitively healthy individuals from the general population. Participants' (n = 226) mean age was 70.9 years (SD = 0.4). CSF concentrations of amyloid beta (Aß)1-42, total tau (t-tau), phosphorylated tau (p-tau), neurogranin, and neurofilament light, and volumes of hippocampus, amygdala, total basal forebrain (TBF), and cortical thickness were measured. Linear associations between CSF biomarkers and MRI measures were investigated. In Aß1-42 positives, higher t-tau and p-tau were associated with smaller hippocampus (P = 0.001 and P = 0.003) and amygdala (P = 0.005 and P = 0.01). In Aß1-42 negatives, higher t-tau, p-tau, and neurogranin were associated with larger TBF volume (P = 0.001, P = 0.001, and P = 0.01). No associations were observed between the CSF biomarkers and an AD signature score of cortical thickness. AD-specific biomarkers in cognitively healthy 70-year-olds may be related to TBF, hippocampus, and amygdala. Lack of association with cortical thickness might be due to early stage of disease.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Alzheimers Dement (Amst) Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Alzheimers Dement (Amst) Año: 2024 Tipo del documento: Article